A
AGIO
Agios Pharmaceuticals, Inc. Common Stock
$30.97
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Agios Pharmaceuticals, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$7.01
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$1.24
Nov 5
Posts
No posts about AGIO yet.
About Agios Pharmaceuticals, Inc. Common Stock
Agios Pharmaceuticals is a US biotechnology company that develops medicines for rare blood diseases. Its main product is Pyrukynd, a pill for a rare condition where red blood cells break down too early. The company sells the drug and spends heavily on research to expand it to other blood disorders such as thalassemia and sickle cell disease.